Home › NDC Lookup › Ingredients › Paroxetine Hydrochloride › 65841-0601-05
Paroxetine 40 mg Tablet, Film Coated, 500-count — NDC 65841-0601-05 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Paroxetine 40 mg Tablet, Film Coated, 500-count — NDC 65841-601-05 (Billing 65841-0601-05)

by Zydus Lifesciences Limited · 500 TABLET, FILM COATED in 1 BOTTLE

This is a package of 500 tablets of Paroxetine 40 mg Tablet, Film Coated from Zydus Lifesciences Limited, marketed since Apr 2007 and currently FDA-listed.

NDC 65841-0601-05
🏷️ FDA NDC (as labeled) 65841-601-05 billing pads the product segment with a zero
This package
Contains500-count Pack sizes5 compare ↓
Also priced by: Part D plans $0.2824/unit — full pricing hub ↓
Product page 65841-0601-01 Also comes in: 30 tablets 65841-601-06 90 tablets 65841-601-16 100 tablets 65841-601-01 1000 tablets 65841-601-10
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 65841-601-05 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
65841 labeler · 601 product · 05 package
Package marketed since
Apr 13, 2007
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 6584160105 3
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 65841-601-05
Product NDC 65841-601
11-digit billing NDC 65841060105
RxCUI 1738483, 1738495, 1738503, 1738511
UNII 3I3T11UD2S
Application # ANDA077584
SPL Set ID 6d5fcdb2-4d84-4b20-87e3-58a43e567500
Established class (EPC) Serotonin Reuptake Inhibitor
Mechanism of action Serotonin Uptake Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2007-04-13
Route ORAL
Dosage form TABLET, FILM COATED
Substance PAROXETINE HYDROCHLORIDE ANHYDROUS
TE code (Orange Book) AB · RLD · RS
Quick answers
  • RxCUI (RxNorm): 1738483
Why two NDCs? The FDA registers this code as 65841-601-05 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65841-0601-05. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Serotonin Reuptake Inhibitor class.

Pharmacologic class Serotonin Reuptake Inhibitor
Drug family (ATC) Selective serotonin reuptake inhibitors
How it works Serotonin Uptake Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Tablets and oral suspension treat depression, OCD, panic disorder, social anxiety, generalized anxiety, and PTSD in adults. Extended-release tablets trea...
  • Take it once a day, usually in the morning, with or without food. The menopause capsule is taken at bedtime. Swallow extended-release tablets whole, and shake the suspension well....
  • The most common are nausea, sleepiness, dry mouth, sweating, constipation or diarrhea, dizziness, trouble sleeping, and sexual side effects. Tell me or your doctor if they're bothe...
  • Yes. Never combine it with MAOIs, thioridazine, or pimozide. Be careful with other serotonin-affecting drugs like triptans, tramadol, or St. John's Wort, and with aspirin, NSAIDs,...
📖 Read our full Paroxetine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
1
Nutrient depletion considerations

Paroxetine may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Paroxetine nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.2824 $141.20 / 500 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
65841-0601-01 65841-601-01 Main listing 100 TABLET, FILM COATED in 1 BOTTLE 2007-04-13 — Active
65841-0601-05 You're viewing this 500 TABLET, FILM COATED in 1 BOTTLE 2007-04-13 — Active
65841-0601-06 65841-601-06 30 TABLET, FILM COATED in 1 BOTTLE 2007-04-13 — Active
65841-0601-10 65841-601-10 1000 TABLET, FILM COATED in 1 BOTTLE 2007-04-13 — Active
65841-0601-16 65841-601-16 90 TABLET, FILM COATED in 1 BOTTLE 2007-04-13 — Active

You're viewing one of 5 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 500-count package — 500 tablet, film coated in 1 bottle.
How does this package differ from NDC 65841-0601-06?
Both are Paroxetine 40 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 500-count one, while NDC 65841-0601-06 is the 30 tablets package.
What NDC number is used to bill for this package of Paroxetine 40 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Paroxetine 40 mg 00378-7004-10 Mylan 1000 tablets $0.097 AB Availability likely —
Paroxetine 40 mg 16714-0184-01 NorthStar 30 tablets $0.097 AB Availability likely —
Paroxetine 40 mg 43547-0350-03 Solco 30 tablets $0.097 AB Availability likely —
Paroxetine 40 mg 50268-0643-15 AvPAK 1 tablet $0.097 AB Availability likely —
Paroxetine 40 mg 60505-0101-01 Apotex 30 tablets $0.097 AB Availability likely —
Paroxetine 40 mg 62135-0544-90 Chartwell 90 tablets $0.097 AB Availability likely —
Paroxetine 40 mg 68084-0047-01 American 1 tablet $0.097 AB Availability likely —
paroxetine hydrochloride 40 mg 69584-0674-03 Oxford 30 tablets $0.097 AB Availability likely —
Paxil 40 mg 60505-4520-03 Apotex 30 tablets $11.505 AB Availability likely —
Paroxetine 40 mg 00615-8174-39 NCS 30 tablets — AB FDA listed —
Paroxetine 40 mg 13107-0157-01 Aurolife 100 tablets — AB FDA listed —
Paroxetine 40 mg 43353-0544-15 Aphena 15 tablets — AB FDA listed —
Paroxetine 40 mg 55289-0053-45 PD-Rx 45 tablets — AB FDA listed —
Paroxetine 40 mg 60429-0737-10 Golden 1000 tablets — AB FDA listed —
Paroxetine 40 mg 61919-0513-90 DIRECT 90 tablets — AB FDA listed —
Paroxetine 40 mg 63187-0434-30 Proficient 30 tablets — AB FDA listed —
Paroxetine 40 mg 63629-3349-01 Bryant 30 tablets — AB FDA listed —
Paroxetine 40 mgthis 65841-0601-05 Zydus 500 tablets — AB FDA listed —
Paroxetine 40 mg 65862-0157-01 Aurobindo 100 tablets — AB FDA listed —
Paroxetine 40 mg 67544-0492-15 Aphena 15 tablets — AB FDA listed —
Paroxetine 40 mg 68382-0001-01 Zydus 100 tablets — AB FDA listed —
Paroxetine 40 mg 68788-6870-01 Preferred 100 tablets — AB FDA listed —
Paroxetine 40 mg 69117-0027-01 Yiling 30 tablets — AB FDA listed —
Paroxetine 40 mg 70518-0003-00 REMEDYREPACK 30 tablets — AB FDA listed —
Paroxetine 40 mg 70518-0993-01 REMEDYREPACK 1 tablet — AB FDA listed —
Paroxetine 40 mg 70518-1253-01 REMEDYREPACK 1 tablet — AB FDA listed —
Paroxetine 40 mg 71205-0198-30 Proficient 30 tablets — AB FDA listed —
Paroxetine 40 mg 71610-0056-15 Aphena 15 tablets — AB FDA listed —
Paroxetine 40 mg 71610-0992-30 Aphena 30 tablets — AB FDA listed —
Paroxetine 40 mg 72162-2358-09 Bryant 90 tablets — AB FDA listed —
Paroxetine 40 mg 72789-0420-90 PD-Rx 90 tablets — AB FDA listed —
Paroxetine 40 mg 76420-0719-01 Asclemed 100 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2007
On the market since
Apr 2007
📍
2026
Currently FDA-listed
19 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeRound
ImprintZC18
Size11 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Paroxetine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII L11K75P92J
    A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
  • UNII 3SY5LH9PMK
    Anhydrous lactose is a milk sugar with no water content. It acts as a filler and binder in tablets and capsules, adding bulk and helping ingredients stick together.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 30IQX730WE
    Polyethylene glycol 6000 is a synthetic polymer made from ethylene glycol units. It acts as a binder, filler, and solubilizer in medicines to help hold ingredients together, add bulk, and improve how well active drugs dissolve and absorb.
  • UNII FZ989GH94E
    Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII 5856J3G2A2
    A starch-based powder made from potatoes and processed with sodium. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the medicine can be absorbed.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

9 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS PHARMACEUTICALS USA INC
FDA applicationANDA077584 (ANDA)
Labeler code65841
First marketedApr 2007
Product typeHuman Prescription Drug
Portfolio720 products on file

More NDCs from Zydus Lifesciences Limited labeler code 65841

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
💬 Medication Guide 📄 Package Label / Principal Display Panel
💬 Medication Guide 2 words ▾

SPL MEDGUIDE

📄 Package Label / Principal Display Panel 92 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-097-06 in pack count of 30 tablets Paroxetine Tablets USP, 10 mg R x only 30 tablets NDC 65841-098-06 in pack count of 30 tablets Paroxetine Tablets USP, 20 mg R x only 30 tablets NDC 65841-099-06 in pack count of 30 tablets Paroxetine Tablets USP, 30 mg R x only 30 tablets NDC 65841-601-06 in pack count of 30 tablets Paroxetine Tablets USP, 40 mg R x only 30 tablets Paroxetine tablets, 10 mg Paroxetine tablets, 20 mg Paroxetine tablets, 30 mg Paroxetine tablets, 40 mg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 30 tablets (65841-0601-06), 90 tablets (65841-0601-16), 100 tablets (65841-0601-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 65841-0538-01 · Zydus 65841-0602-01 · Zydus →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.